Skip to main content

Lisinopril

NDC 70518-3166 · REMEDYREPACK INC.

Generic nameLisinopril
Dosage formTABLET
RouteORAL
Active ingredient(s)LISINOPRIL
Strength40 mg/1
Pharmacologic classAngiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]
Marketing categoryANDA

Packages

70518-3166-0 — 30 TABLET in 1 BLISTER PACK (70518-3166-0)

70518-3166-1 — 90 TABLET in 1 BOTTLE, PLASTIC (70518-3166-1)

70518-3166-3 — 100 TABLET in 1 BOTTLE, PLASTIC (70518-3166-3)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

70518-0468 — Lisinopril, 70518-0544 — Lisinopril, 70518-0845 — Lisinopril, 70518-1152 — Lisinopril, 70518-1156 — Lisinopril, 70518-1316 — Lisinopril, 70518-1565 — Lisinopril, 70518-1790 — Lisinopril, 70518-1906 — Lisinopril, 70518-2561 — Lisinopril, 70518-3505 — Lisinopril and Hydrochlorothiazide Tablets, 70518-4397 — Lisinopril, 70518-4509 — lisinopril, 70518-4516 — Lisinopril and Hydrochlorothiazide Tablets, 71205-022 — Lisinopril and Hydrochlorothiazide, 71205-071 — Lisinopril, 71205-180 — Lisinopril, 71205-471 — Lisinopril, 71205-626 — Lisinopril, 71205-742 — Lisinopril, +342 more

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels